These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 11555601

  • 1. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
    Raida M, Schwabe W, Häusler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Höffken K.
    Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
    [Abstract] [Full Text] [Related]

  • 2. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
    Innocenti F, Ratain MJ.
    Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
    Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB.
    Clin Cancer Res; 1999 Aug; 5(8):2006-11. PubMed ID: 10473079
    [Abstract] [Full Text] [Related]

  • 5. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity.
    Kouwaki M, Hamajima N, Sumi S, Nonaka M, Sasaki M, Dobashi K, Kidouchi K, Togari H, Wada Y.
    Clin Cancer Res; 1998 Dec; 4(12):2999-3004. PubMed ID: 9865912
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Dec; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 8. [Detection of DPD-exon-14 skipping before 5-fluorouracil treatment?].
    Kliche KO.
    Dtsch Med Wochenschr; 2002 Mar 01; 127(9):463-4. PubMed ID: 11870563
    [No Abstract] [Full Text] [Related]

  • 9. DPYD*2A mutation: the most common mutation associated with DPD deficiency.
    Saif MW, Ezzeldin H, Vance K, Sellers S, Diasio RB.
    Cancer Chemother Pharmacol; 2007 Sep 01; 60(4):503-7. PubMed ID: 17165084
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacogenetics in oncology: 5-fluorouracil and the dihydropyrimidine dehydrogenase].
    Lazar A, Jetter A.
    Dtsch Med Wochenschr; 2008 Jul 01; 133(28-29):1501-4. PubMed ID: 18597209
    [Abstract] [Full Text] [Related]

  • 11. Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy.
    Morrison GB, Bastian A, Dela Rosa T, Diasio RB, Takimoto CH.
    Oncol Nurs Forum; 1997 Jul 01; 24(1):83-8. PubMed ID: 9007910
    [Abstract] [Full Text] [Related]

  • 12. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.
    van Kuilenburg AB.
    Eur J Cancer; 2004 May 01; 40(7):939-50. PubMed ID: 15093568
    [Abstract] [Full Text] [Related]

  • 13. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
    Johnson MR, Wang K, Diasio RB.
    Clin Cancer Res; 2002 Mar 01; 8(3):768-74. PubMed ID: 11895907
    [Abstract] [Full Text] [Related]

  • 14. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
    Ogura K.
    Gan To Kagaku Ryoho; 2006 Aug 01; 33(8):1041-8. PubMed ID: 16912518
    [Abstract] [Full Text] [Related]

  • 15. Identification of a novel mutation in the dihydropyrimidine dehydrogenase gene in a patient with a lethal outcome following 5-fluorouracil administration and the determination of its frequency in a population of 500 patients with colorectal carcinoma.
    Morel A, Boisdron-Celle M, Fey L, Lainé-Cessac P, Gamelin E.
    Clin Biochem; 2007 Jan 01; 40(1-2):11-7. PubMed ID: 17046731
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between dihydropyrimidine dehydrogenase(DPD) activity and toxicity of 5-FU-based adjuvant chemotherapy in colorectal cancer patients].
    Zhou ZW, Wang GQ, Wan DS, Pan ZZ, Li S, Chen G, Liao H.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1512-6. PubMed ID: 15566669
    [Abstract] [Full Text] [Related]

  • 17. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R.
    Clin Cancer Res; 2003 Feb 01; 9(2):786-91. PubMed ID: 12576451
    [Abstract] [Full Text] [Related]

  • 18. [Relationship of serum level of dihydropyrimidine dehydrogenase and serum concentration of 5-fluorouracil to treatment response and adverse events in colorectal cancer patients].
    Dong QM, He YJ, Li S, Zhou ZM, Zhang L, Zhou ZW, Xia ZJ, Li YY.
    Ai Zheng; 2005 Apr 01; 24(4):483-7. PubMed ID: 15820075
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.
    Van Kuilenburg AB, Meinsma R, Zoetekouw L, Van Gennip AH.
    Int J Cancer; 2002 Sep 20; 101(3):253-8. PubMed ID: 12209976
    [Abstract] [Full Text] [Related]

  • 20. Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity.
    Van Kuilenburg AB, Vreken P, Beex LV, Meinsma R, Van Lenthe H, De Abreu RA, van Gennip AH.
    Eur J Cancer; 1997 Nov 20; 33(13):2258-64. PubMed ID: 9470816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.